Certificate of Analysis
Third Party Tested
Molecular Profile
Compound
Thymosin Alpha-1
Batch #
P241209-LC502108
Formula
C129H215N33O55
Mol Wt
3108.3 g/mol
CAS
62304-98-7
Latest
ISO 17025
8× Testing
99.84%
Purity
VariantThymosin
COA ##11584
Labeled10mg
Validation KeyAXISBIOTECH
Tested12/16/25
Full QC Panel - 8× tested
✓
Purity (HPLC) - 99.84%
✓
Net Peptide Content - 10mg
✓
Identity (HPLC) - Thymosin
✓
Fentanyl Screen - Not Detected
✓
HPLC Conformity mean - >99%
✓
ISO/IEC 17025 Accredited
Storage Requirements
Stability Information
Lyophilized (powder)
−20°C long-term
2–8°C
Reconstituted
Recommended condition
Light protection
Store away from light
Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.
Peer-Reviewed Literature
Research & References
Research and reference material related to this compound.
01
Preparation and properties of thymosin, a thymic polypeptide causing lymphocyte differentiation
02
Thymosin alpha 1 as an immunomodulator in chronic hepatitis B
03
Thymalfasin (thymosin alpha-1) for the treatment of hepatitis B and C
04
Thymosin alpha-1 as a potential modulator of immunity in COVID-19
05
The thymosin alpha 1 peptide: 40 years of scientific progress
Safety & Regulatory Compliance Warning
These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.
